363 related articles for article (PubMed ID: 29212715)
1. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions.
Fard MK; van der Meer F; Sánchez P; Cantuti-Castelvetri L; Mandad S; Jäkel S; Fornasiero EF; Schmitt S; Ehrlich M; Starost L; Kuhlmann T; Sergiou C; Schultz V; Wrzos C; Brück W; Urlaub H; Dimou L; Stadelmann C; Simons M
Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212715
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD.
Jiang G; Ayaki T; Maki T; Yasuda K; Yoshii D; Kaji S; Takahashi R
Neurosci Lett; 2023 Aug; 812():137405. PubMed ID: 37479175
[TBL] [Abstract][Full Text] [Related]
3. Lack of astrocytes hinders parenchymal oligodendrocyte precursor cells from reaching a myelinating state in osmolyte-induced demyelination.
Lohrberg M; Winkler A; Franz J; van der Meer F; Ruhwedel T; Sirmpilatze N; Dadarwal R; Handwerker R; Esser D; Wiegand K; Hagel C; Gocht A; König FB; Boretius S; Möbius W; Stadelmann C; Barrantes-Freer A
Acta Neuropathol Commun; 2020 Dec; 8(1):224. PubMed ID: 33357244
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
5. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
6. Lesion stage-dependent causes for impaired remyelination in MS.
Heß K; Starost L; Kieran NW; Thomas C; Vincenten MCJ; Antel J; Martino G; Huitinga I; Healy L; Kuhlmann T
Acta Neuropathol; 2020 Sep; 140(3):359-375. PubMed ID: 32710244
[TBL] [Abstract][Full Text] [Related]
7. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking BCAS1, a novel myelin-associated protein, display hypomyelination, schizophrenia-like abnormal behaviors, and upregulation of inflammatory genes in the brain.
Ishimoto T; Ninomiya K; Inoue R; Koike M; Uchiyama Y; Mori H
Glia; 2017 May; 65(5):727-739. PubMed ID: 28230289
[TBL] [Abstract][Full Text] [Related]
9. Limited TCF7L2 expression in MS lesions.
Lürbke A; Hagemeier K; Cui QL; Metz I; Brück W; Antel J; Kuhlmann T
PLoS One; 2013; 8(8):e72822. PubMed ID: 23977356
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocytes in Development, Myelin Generation and Beyond.
Kuhn S; Gritti L; Crooks D; Dombrowski Y
Cells; 2019 Nov; 8(11):. PubMed ID: 31726662
[TBL] [Abstract][Full Text] [Related]
11. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis.
Kuhlmann T; Miron V; Cui Q; Wegner C; Antel J; Brück W
Brain; 2008 Jul; 131(Pt 7):1749-58. PubMed ID: 18515322
[TBL] [Abstract][Full Text] [Related]
12. BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy.
Kaji S; Maki T; Ueda J; Ishimoto T; Inoue Y; Yasuda K; Sawamura M; Hikawa R; Ayaki T; Yamakado H; Takahashi R
Acta Neuropathol Commun; 2020 Jul; 8(1):120. PubMed ID: 32727582
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of oligodendrocyte generation in multiple sclerosis.
Yeung MSY; Djelloul M; Steiner E; Bernard S; Salehpour M; Possnert G; Brundin L; Frisén J
Nature; 2019 Feb; 566(7745):538-542. PubMed ID: 30675058
[TBL] [Abstract][Full Text] [Related]
15. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
16. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
17. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
Vana AC; Lucchinetti CF; Le TQ; Armstrong RC
Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
[TBL] [Abstract][Full Text] [Related]
18. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B
Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253
[TBL] [Abstract][Full Text] [Related]
19. A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
Ahmad I; Wergeland S; Oveland E; Bø L
PLoS One; 2021; 16(8):e0256155. PubMed ID: 34437581
[TBL] [Abstract][Full Text] [Related]
20. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
